On Wednesday, Telesta Therapeutics (TSX:TST) announced it had entered into a licensing agreement with French pharmaceutical company, Ipsen, whereby … [Read more...] about Telesta Therapeutics has a date with FDA destiny
Valeant Pharmaceuticals (TSX:VRX), Canada’s largest and most recognizable healthcare company, has taken an incredible beating over the past … [Read more...] about Is Bill Ackman right about Valeant Pharmaceuticals?
Today, Tekmira began trading under its new name and new symbol, Arbutus Biopharma Corporation, "ABUS" on Nasdaq. This is one of the final steps in … [Read more...] about Tekmira: Goodbye Old Friend
On Friday, in a somewhat ambiguous news release, Tekmira updated investors on the Phase II ebola study being run in Sierra Leone with its RNA … [Read more...] about What Does the Future Hold for Tekmira’s Ebola Program?
This morning, Quebec City-based Opsens (TSXV:OPS) announced it had received FDA 510(k) clearance to market its fractional flow reserve (FFR) … [Read more...] about A Regulatory Hat-Trick: Opsens OptoWire Cleared for Sale in Japan, Europe, and now U.S
I am a proud Manitoban, and not only do I cheer for the Jets, I cheer for all things Manitoba. I cut my life science teeth so-to-speak, as a drug rep … [Read more...] about Medicure is Persevering on the Prairies
It would be an understatement to say that specialty pharma companies have been popular among Canadian investors of late. A quick scan of the one-year … [Read more...] about Theratechnologies Is Reinventing Itself
Oncolytics Biotech (TSX:ONC, Nasdaq:ONCY) yesterday announced it had received orphan drug designation from FDA for their oncology drug, REOLYSIN, in … [Read more...] about Oncolytics Biotech and Orphan Drug Designations: Wash, Rinse, Repeat
This past Friday, the tape was telling investors that something was up at Prometic Life Sciences (TSX:PLI). Prometic stock was surging on above … [Read more...] about Prometic Life Sciences should have strong clinical news flow in 2015
This week, Quebec City based, TSO3 (TSX:TOS), announced a $10 million bought deal financing co-led by Desjardins and Canaccord. As I discussed in … [Read more...] about TSO3 Goes it Alone. But For How Long?